Keith L Knutson, PhD

  • 11259 Citations
  • 49 Scopus h-Index
1993 …2020
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Keith L Knutson is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 16 Similar Profiles
Neoplasms Medicine & Life Sciences
T-Lymphocytes Medicine & Life Sciences
Ovarian Neoplasms Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Immunity Medicine & Life Sciences
Subunit Vaccines Medicine & Life Sciences
Neoplasm Antigens Medicine & Life Sciences
Vaccines Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2004 2020

Poisoning of PARP and Topoisomerase I to Treat Ovarian Cancer

Kaufmann, S. H., Cliby, W. A., Bible, K. C., Goode, E. L., Galanis, E., Knutson, K. L., Hartmann, L. C., Oberg, A. L., Couch, F. J., Fields, A. P., Haluska, P. R. J., Long, H., Bell, D., Keeney, G., Lengyel, E., Keeney, G., Shridhar, V., Cliby, W. A., Goode, E. L., Peng, K., Hartmann, L. C. & Lingle, W. L.

National Institutes of Health

10/1/088/31/20

Project: Research project

Ovarian Neoplasms
alvocidib
Registries
Research
Translational Medical Research

Role of Immunity in Efficacy of Chemotherapy Plus Trastuzumab

Perez, E. A., Clynes, R. & Knutson, K. L.

National Institutes of Health

1/1/1112/31/16

Project: Research project

Immunity
Drug Therapy
Breast Neoplasms
Antibody Formation
Trastuzumab
Folate Receptor 1
Folic Acid
Ovarian Neoplasms
Antibodies
Serum
Immunity
Histocompatibility Antigens Class I
Breast Neoplasms
Peptides
Neoplasm Antigens
Helper-Inducer T-Lymphocytes
Cytotoxic T-Lymphocytes
Neoplasms
T-Lymphocytes
Th2 Cells

Research Output 1993 2019

  • 11259 Citations
  • 49 Scopus h-Index
  • 145 Article
  • 3 Chapter
  • 2 Review article
  • 1 Comment/debate

Effects of age and immune landscape on outcome in HER2-positive breast cancer in the NCCTG N9831 (Alliance) and NSABP B-31 (NRG) trials

Chumsri, S., Serie, D. J., Li, Z., Pogue-Geile, K. L., Soyano-Muller, A. E., Mashadi-Hossein, A., Warren, S., Lou, Y., Colon-Otero, G., Knutson, K. L., Perez, E. A., Moreno Aspitia, A. & Thompson, E. A., Jan 1 2019, In : Clinical Cancer Research. 25, 14, p. 4422-4430 9 p.

Research output: Contribution to journalArticle

Breast Neoplasms
adjuvant P40
B 31
Trastuzumab

Hypereosinophilia in a patient with metastatic non-small-cell lung cancer treated with antiprogrammed cell death 1 (anti-PD-1) therapy

Lou, Y., Marin-Acevedo, J. A., Vishnu, P., Manochakian, R., Dholaria, B., Soyano, A., Luo, Y., Zhang, Y. & Knutson, K. L., May 1 2019, In : Immunotherapy. 11, 7, p. 577-584 8 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Eosinophilia
Cell Death
Therapeutics
Eosinophils
1 Citation (Scopus)

The evolving clinical landscape for dendritic cell vaccines and cancer immunotherapy

Cannon, M. J., Block, M. S., Morehead, L. C. & Knutson, K. L., Feb 1 2019, In : Immunotherapy. 11, 2, p. 75-79 5 p.

Research output: Contribution to journalComment/debate

Cancer Vaccines
Glioblastoma
Pancreatic Neoplasms
Acute Myeloid Leukemia
Ovarian Neoplasms
39 Citations (Scopus)

Cancer immunotherapy beyond immune checkpoint inhibitors

Marin-Acevedo, J. A., Soyano, A. E., Dholaria, B., Knutson, K. L. & Lou, Y., Jan 12 2018, In : Journal of Hematology and Oncology. 11, 1, 8.

Research output: Contribution to journalReview article

Immunotherapy
Immune System
Neoplasms
CD274 Antigen
Programmed Cell Death 1 Receptor
8 Citations (Scopus)

Folate receptor alpha peptide vaccine generates immunity in breast and ovarian cancer patients

Kalli, K. R., Block, M. S., Kasi, P. M., Erskine, C. L., Hobday, T. J., Dietz, A. B., Padley, D., Gustafson, M., Shreeder, B., Puglisi-Knutson, D., Visscher, D. W., Mangskau, T. K., Wilson, G. & Knutson, K. L., Jul 1 2018, In : Clinical Cancer Research. 24, 13, p. 3014-3025 12 p.

Research output: Contribution to journalArticle

Folate Receptor 1
Subunit Vaccines
Ovarian Neoplasms
Immunity
Breast Neoplasms